TRVI
Trevi Therapeutics·NASDAQ
--
--(--)
--
--(--)
TRVI Filings
Filing Date
Form Description
Form Type
2026-02-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-12
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-12 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2025-12-05
Form 8-K - Current report
Key Events
2025-12-05 · Key Events
Form 8-K - Current report
2025-12-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-13 · Earnings Call
Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript
2025-11-13
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-11-13 ·
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
